Status:
UNKNOWN
Analysis of Ocular and Neurodevelopmental Function for Retinopathy of Prematurity
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Retinopathy of Prematurity
Neurodevelopmental Abnormality
Eligibility:
All Genders
3-12 years
Brief Summary
The goal of this research project is to identify the long-term outcome of neurodevelopment in patients with retinopathy of prematurity(ROP) and the treatment of anti-vascular endothelial growth factor...
Detailed Description
Retinopathy of Prematurity and Vascular Endothelial Growth Factor (VEGF) Retinopathy of prematurity (ROP) is a retinal disease in preterm infants due to retinal vessels immaturity, characterized by re...
Eligibility Criteria
Inclusion
- Patients now aged 3 to12-years-old
- Premature without ROP
- ROP without treatment
- ROP with laser photocoagulation treatment
- ROP with anti-VEGF treatment
- ROP with laser photocoagulation + anti-VEGF treatment
- Fullterm
Exclusion
- Patients have brain's disease
- Patients have Scleral buckling which is a type of eye surgery
- Patients have Trans pars plana vitrectomy which is a type of eye surgery
- Patients have other eye surgery
- Patients have nystagmus
- Patients can not Cooperate to complete the text
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
510 Patients enrolled
Trial Details
Trial ID
NCT05186155
Start Date
January 1 2019
End Date
March 31 2022
Last Update
January 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Chang Gung Memorial Hospital.
Linkou District, Taoyuan, Taiwan, 33305